Terms: = Lung cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809
2034 results:
1. Combination of betulinic acid and EGFR-TKIs exerts synergistic anti-tumor effects against wild-type EGFR NSCLC by inducing autophagy-related cell death via EGFR signaling pathway.
Wang H; Du X; Liu W; Zhang C; Li Y; Hou J; Yu Y; Li G; Wang Q
Respir Res; 2024 May; 25(1):215. PubMed ID: 38764025
[TBL] [Abstract] [Full Text] [Related]
2. Giant Renal Angiomyolipomas and Pulmonary Lymphangioleiomyomatosis: Follow-up Report after More than a Decade.
Nasir K; Ahmad A
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):671-675. PubMed ID: 38725217
[TBL] [Abstract] [Full Text] [Related]
3. TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway.
Huang S; Zhao H; Lou X; Chen D; Shi C; Ren Z
Biochem Biophys Res Commun; 2024 Jul; 718():149983. PubMed ID: 38718735
[TBL] [Abstract] [Full Text] [Related]
4. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
[TBL] [Abstract] [Full Text] [Related]
5. Inhalation exposure-induced toxicity and disease mediated via mtor dysregulation.
Shinde A; Shannahan J
Exp Biol Med (Maywood); 2024; 249():10135. PubMed ID: 38711460
[TBL] [Abstract] [Full Text] [Related]
6. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J
Gene; 2024 Aug; 918():148474. PubMed ID: 38670393
[TBL] [Abstract] [Full Text] [Related]
7. Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer.
Wang Y; Huang Z; Li B; Xue J; Guo C; Bing Z; Zheng Z; Song Y; Xu Y; Huang G; Li H; Yu X; Xia Y; Li R; Si X; Zhang L; Li J; Song L; Xiong Y; Gu D; Song M; Zhou Z; Chen R; Feng Z; Bie Z; Li X; Yang H; Li S; Liang N
Cancer Immunol Immunother; 2024 Apr; 73(6):111. PubMed ID: 38668781
[TBL] [Abstract] [Full Text] [Related]
8. Targeted inhibition of the PI3K/AKT/mtor pathway by (+)-anthrabenzoxocinone induces cell cycle arrest, apoptosis, and autophagy in non-small cell lung cancer.
Li XQ; Cheng XJ; Wu J; Wu KF; Liu T
Cell Mol Biol Lett; 2024 Apr; 29(1):58. PubMed ID: 38649803
[TBL] [Abstract] [Full Text] [Related]
9. FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression.
Wu J; Wen T; Marzio A; Song D; Chen S; Yang C; Zhao F; Zhang B; Zhao G; Ferri A; Cheng H; Ma J; Ren H; Chen QY; Yang Y; Qin S
Cell Death Dis; 2024 Apr; 15(4):282. PubMed ID: 38643215
[TBL] [Abstract] [Full Text] [Related]
10. 13-Oxyingenol-dodecanoate inhibits the growth of non-small cell lung cancer cells by targeting ULK1.
Wang XY; Wang YJ; Guo BW; Hou ZL; Zhang GX; Han Z; Liu Q; Yao GD; Song SJ
Bioorg Chem; 2024 Jun; 147():107367. PubMed ID: 38626492
[TBL] [Abstract] [Full Text] [Related]
11. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.
Zhou X; Zhao J; Yan T; Ye D; Wang Y; Zhou B; Liu D; Wang X; Zheng W; Zheng B; Qian F; Li Y; Li D; Fang L
Cell Death Dis; 2024 Apr; 15(4):260. PubMed ID: 38609357
[TBL] [Abstract] [Full Text] [Related]
12. A role for RIO kinases in the crosshair of cancer research and therapy.
Ghandadi M; Dobi A; Malhotra SV
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189100. PubMed ID: 38604268
[TBL] [Abstract] [Full Text] [Related]
13. Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2.
Sun H; Zhu R; Guo X; Zhao P; Zhang R; Zhao Z; Zhou H
Pathol Res Pract; 2024 Apr; 256():155271. PubMed ID: 38574630
[TBL] [Abstract] [Full Text] [Related]
14. The new N
Liu J; Nie W; Nie H; Yao H; Ren Y; Cao L; Qiu J; Wang M; Li X; An B; Jia X
Bioorg Chem; 2024 May; 146():107313. PubMed ID: 38554675
[TBL] [Abstract] [Full Text] [Related]
15. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mtor signalling cascade.
Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
[TBL] [Abstract] [Full Text] [Related]
16. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
Johnson J; Somerfield W; Johnson SR
Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
[TBL] [Abstract] [Full Text] [Related]
17. Recent advances in the therapeutic potential of nobiletin against respiratory diseases.
Qin Y; Yang J; Li H; Li J
Phytomedicine; 2024 Jun; 128():155506. PubMed ID: 38522319
[TBL] [Abstract] [Full Text] [Related]
18. Concurrent inhibition of ALK and SRC kinases disrupts the ALK lung tumor cell proteome.
Diaz-Jimenez A; Ramos M; Helm B; Chocarro S; Frey DL; Agrawal S; Somogyi K; Klingmüller U; Lu J; Sotillo R
Drug Resist Updat; 2024 May; 74():101081. PubMed ID: 38521003
[TBL] [Abstract] [Full Text] [Related]
19. Scutellarin, a flavonoid compound from Scutellaria barbata, suppresses growth of breast cancer stem cells in vitro and in tumor-bearing mice.
Ma H; Yue GG; Lee JK; Gao S; Yuen KK; Cheng W; Li X; Lau CB
Phytomedicine; 2024 Jun; 128():155418. PubMed ID: 38518647
[TBL] [Abstract] [Full Text] [Related]
20. mtor hyperactivity and
Sztankovics D; Moldvai D; Petővári G; Dankó T; Szalai F; Miyaura R; Varga V; Nagy N; Papp G; Pápay J; Krencz I; Sebestyén A
Pathol Oncol Res; 2024; 30():1611643. PubMed ID: 38515456
[TBL] [Abstract] [Full Text] [Related]
[Next]